James P. Dunn, MD

Dr. Dunn, associate professor of ophthalmology, division of ocular immunology. The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore.


Biologic agents treat ocular inflammatory disease

Editor's Note: As defined by the FDA, the term "biologics" refers to a wide range of products that includes vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins, such as monoclonal antibodies and antibody fragments.